심혈관용 디지털 헬스 시장 규모, 점유율, 동향 분석 보고서 : 구성 요소별, 최종 용도별, 지역별, 부문 예측(2025-2030년)

Digital Health For Cardiovascular Market Growth & Trends:

The global digital health for cardiovascular market size is anticipated to reach USD 140.96 billion by 2030, registering a CAGR of 22.5% from 2025 to 2030, according to a new report by Grand View Research, Inc. The market is driven by the increasing prevalence of cardiovascular diseases (CVDs), rapid advancements in healthcare technology, along with rising healthcare funding and expenditure boosting the growing demand for remote patient monitoring services; for instance, in August 2023, Monitra Healthcare, a remote heart monitoring platform raised a funding of USD 500K, which further aimed at expanding the services and distribution channel across India for remotely monitoring blood pressure, oxygen saturation, and respiratory rate across biomarkers which were in contact with patients.

There is an increasing demand for telehealth services in several regions due to the growing elderly population and rising prevalence of cardiovascular diseases. According to WHO estimates, the population aged 60 years or over is estimated to reach 2.1 billion by 2050 globally. Moreover, the middle class and affluent population across the globe are also growing rapidly. According to the Unit ed Nations report, it is expected that the population aged 65 and above will rise from 10% to 16% from 2022 to 2050. The increasing healthcare needs and shortage of medical professionals are anticipated to drive the market growth.

E-Health adoption is on the rise in developing nations, with countries like India, China, Brazil, and Mexico implementing eHealth strategies. Government efforts, including awareness programs and healthcare IT research & development funding, are expected to foster mHealth adoption in these regions. For instance, in November 2023, Versicles Technologies, a start-up from Kerala, India, launched its Prognosis app as Kiosk', which is developed to provide basic diagnostics care like blood sugar, blood pressure, and heart conditions at extremely low prices, with utmost accuracy. Moreover, various apps, such as Practo, AssistRx, and Wareed, have emerged globally over the last decade to assist patients in booking appointments, monitoring consultations and prescriptions, and managing their health information throughout treatment.

Several key players are acquiring other manufacturers, operating on a small scale, to extend their portfolio and product lines and strengthen their market positions. For instance, in September 2022, PrepMD RMS, a company providing premier remote cardiac clinical solutions and monitoring, announced the acquisition of Intellectual property and technology assets; this acquisition will help the company for smooth operations in remote monitoring space through its IBHRE-certified team within various cardiology clinics. Such strategic initiatives by the players help bolster market growth.

Furthermore, the growing demand for specialty heart health consulting, especially in remote areas, is one of the significant factors driving the growth of telehealth cardiovascular services. Increasing investments in the telehealth industry is another key factor responsible for the increasing demand in the market. For instance, in November 2023, the American Heart Association received a grant of USD 15.9 million for developing telehealth services and the telehealth community. In another development, in August 2023, telehealth startup Ventricle received USD 8 Million in funding. Furthermore, increasing government initiatives for the development of telehealth programs are expected to propel the growth of these services in the market.

Digital Health For Cardiovascular Market Report Highlights:

• The services segment accounted for the largest market share of 37.9% in 2024. Service providers in the market are offering their solutions both as integrated packages and as individual products.
• The patient segment dominated the digital health for cardiovascular industry with a revenue share of 34.5% in 2024 and is anticipated to witness the fastest growth over the forecast period.
• North America dominated the overall digital health for cardiovascular industry in 2024 with a revenue share of 37.7%, due to the increasing healthcare IT expenditure for supporting digital infrastructure, growing technological advancements, and supportive government initiatives.

Table of Contents

Chapter 1. Methodology and Scope

• 1.1. Market Segmentation & Scope
  • 1.1.1. Segment scope
  • 1.1.2. Regional scope
  • 1.1.3. Estimates and forecast timeline
• 1.2. Research Methodology
• 1.3. Information Procurement
  • 1.3.1. Purchased database
  • 1.3.2. GVR's internal database
  • 1.3.3. Secondary sources
  • 1.3.4. Primary research
  • 1.3.5. Details of primary research
• 1.4. Information or Data Analysis
  • 1.4.1. Data analysis models
• 1.5. Market Formulation & Validation
• 1.6. Model Details
  • 1.6.1. Commodity flow analysis (Model 1)
    • 1.6.1.1. Approach 1: Commodity flow approach
• 1.7. Research Assumptions
• 1.8. List of Secondary Sources
• 1.9. List of Primary Sources

Chapter 2. Executive Summary

• 2.1. Market Outlook
• 2.2. Segment Outlook
  • 2.2.1. Component outlook
  • 2.2.2. End Use outlook
  • 2.2.3. Regional outlook
• 2.3. Competitive Insights

Chapter 3. Digital Health For Cardiovascular Market Variables, Trends & Scope

• 3.1. Market Lineage Outlook
  • 3.1.1. Parent market outlook
  • 3.1.2. Related/ancillary market outlook
• 3.2. Market Dynamics
  • 3.2.1. Market driver analysis
  • 3.2.2. Market restraint analysis
• 3.3. Digital Health For Cardiovascular: Market Analysis Tools
  • 3.3.1. Industry Analysis - Porter's
  • 3.3.2. PESTLE Analysis
• 3.4. Regulatory Landscape
• 3.5. Technology Landscape
• 3.6. Digital Health: Accomplishments and Opportunities Across the Health System Sectors
• 3.7. Analysis on Start-ups and Established Companies in Digital Health For Cardiovascular Market
• 3.8. Healthcare Mobile App Trends
• 3.9. Digital Health For Cardiovascular Market Participants Overview
• 3.10. Digital Health For Cardiovascular Market - Case Study
• 3.11. Digital Health Ecosystem (Patient Centric)
• 3.12. Digital Health Ecosystem (By Companies)
• 3.13. Competitive Ranking
• 3.14. Digital Health Investments

Chapter 4. Digital Health For Cardiovascular Market: Segment Analysis, By Component, 2018 - 2030 (USD Million)

• 4.1. Definition and Scope
• 4.2. Component Market Share Analysis, 2024 & 2030
• 4.3. Segment Dashboard
• 4.4. Global Digital Health For Cardiovascular Market by Component, 2018 to 2030
• 4.5. Software
  • 4.5.1. Market estimates and forecast 2018 to 2030 (USD Million)
• 4.6. Hardware
  • 4.6.1. Market estimates and forecast 2018 to 2030 (USD Million)
• 4.7. Services
  • 4.7.1. Market estimates and forecast 2018 to 2030 (USD Million)

Chapter 5. Digital Health For Cardiovascular Market: Segment Analysis, By End Use, 2018 - 2030 (USD Million)

• 5.1. Definition and Scope
• 5.2. End Use Market Share Analysis, 2024 & 2030
• 5.3. Segment Dashboard
• 5.4. Global Digital Health For Cardiovascular Market by End Use
• 5.5. Patients
  • 5.5.1. Market estimates and forecast 2018 to 2030 (USD Million)
• 5.6. Providers
  • 5.6.1. Market estimates and forecast 2018 to 2030 (USD Million)
• 5.7. Payers
  • 5.7.1. Market estimates and forecast 2018 to 2030 (USD Million)
• 5.8. Others
  • 5.8.1. Market estimates and forecast 2018 to 2030 (USD Million)

Chapter 6. Digital Health For Cardiovascular Segment Analysis, By Region, By Component, By End Use, 2018 - 2030 (USD Million)

• 6.1. Regional Market Share Analysis, 2024 & 2030
• 6.2. Regional Market Dashboard
• 6.3. Regional Market Snapshot
• 6.4. Digital Health For Cardiovascular Market Share by Region, 2024 & 2030 by Region
• 6.5. North America
  • 6.5.1. U.S.
    • 6.5.1.1. Key country dynamics
    • 6.5.1.2. Regulatory framework/ reimbursement structure
    • 6.5.1.3. Competitive scenario
    • 6.5.1.4. U.S. digital health for cardiovascular market estimates and forecasts 2018 to 2030 (USD Million)
  • 6.5.2. Canada
    • 6.5.2.1. Key country dynamics
    • 6.5.2.2. Regulatory framework/ reimbursement structure
    • 6.5.2.3. Competitive scenario
    • 6.5.2.4. Canada digital health for cardiovascular market estimates and forecasts 2018 to 2030 (USD Million)
  • 6.5.3. Mexico
    • 6.5.3.1. Key country dynamics
    • 6.5.3.2. Regulatory framework/ reimbursement structure
    • 6.5.3.3. Competitive scenario
    • 6.5.3.4. Mexico digital health for cardiovascular market estimates and forecasts 2018 to 2030 (USD Million)
• 6.6. Europe
  • 6.6.1. UK
    • 6.6.1.1. Key country dynamics
    • 6.6.1.2. Regulatory framework/ reimbursement structure
    • 6.6.1.3. Competitive scenario
    • 6.6.1.4. UK digital health for cardiovascular market estimates and forecasts 2018 to 2030 (USD Million)
  • 6.6.2. Germany
    • 6.6.2.1. Key country dynamics
    • 6.6.2.2. Regulatory framework/ reimbursement structure
    • 6.6.2.3. Competitive scenario
    • 6.6.2.4. Germany digital health for cardiovascular market estimates and forecasts 2018 to 2030 (USD Million)
  • 6.6.3. France
    • 6.6.3.1. Key country dynamics
    • 6.6.3.2. Regulatory framework/ reimbursement structure
    • 6.6.3.3. Competitive scenario
    • 6.6.3.4. France digital health for cardiovascular market estimates and forecasts 2018 to 2030 (USD Million)
  • 6.6.4. Italy
    • 6.6.4.1. Key country dynamics
    • 6.6.4.2. Regulatory framework/ reimbursement structure
    • 6.6.4.3. Competitive scenario
    • 6.6.4.4. Italy digital health for cardiovascular market estimates and forecasts 2018 to 2030 (USD Million)
  • 6.6.5. Spain
    • 6.6.5.1. Key country dynamics
    • 6.6.5.2. Regulatory framework/ reimbursement structure
    • 6.6.5.3. Competitive scenario
    • 6.6.5.4. Spain digital health for cardiovascular market estimates and forecasts 2018 to 2030 (USD Million)
  • 6.6.6. Norway
    • 6.6.6.1. Key country dynamics
    • 6.6.6.2. Regulatory framework/ reimbursement structure
    • 6.6.6.3. Competitive scenario
    • 6.6.6.4. Norway digital health for cardiovascular market estimates and forecasts 2018 to 2030 (USD Million)
  • 6.6.7. Sweden
    • 6.6.7.1. Key country dynamics
    • 6.6.7.2. Regulatory framework/ reimbursement structure
    • 6.6.7.3. Competitive scenario
    • 6.6.7.4. Sweden digital health for cardiovascular market estimates and forecasts 2018 to 2030 (USD Million)
  • 6.6.8. Denmark
    • 6.6.8.1. Key country dynamics
    • 6.6.8.2. Regulatory framework/ reimbursement structure
    • 6.6.8.3. Competitive scenario
    • 6.6.8.4. Denmark digital health for cardiovascular market estimates and forecasts 2018 to 2030 (USD Million)
• 6.7. Asia Pacific
  • 6.7.1. Japan
    • 6.7.1.1. Key country dynamics
    • 6.7.1.2. Regulatory framework/ reimbursement structure
    • 6.7.1.3. Competitive scenario
    • 6.7.1.4. Japan digital health for cardiovascular market estimates and forecasts 2018 to 2030 (USD Million)
  • 6.7.2. China
    • 6.7.2.1. Key country dynamics
    • 6.7.2.2. Regulatory framework/ reimbursement structure
    • 6.7.2.3. Competitive scenario
    • 6.7.2.4. China digital health for cardiovascular market estimates and forecasts 2018 to 2030 (USD Million)
  • 6.7.3. India
    • 6.7.3.1. Key country dynamics
    • 6.7.3.2. Regulatory framework/ reimbursement structure
    • 6.7.3.3. Competitive scenario
    • 6.7.3.4. India digital health for cardiovascular market estimates and forecasts 2018 to 2030 (USD Million)
  • 6.7.4. Australia
    • 6.7.4.1. Key country dynamics
    • 6.7.4.2. Regulatory framework/ reimbursement structure
    • 6.7.4.3. Competitive scenario
    • 6.7.4.4. Australia digital health for cardiovascular market estimates and forecasts 2018 to 2030 (USD Million)
  • 6.7.5. South Korea
    • 6.7.5.1. Key country dynamics
    • 6.7.5.2. Regulatory framework/ reimbursement structure
    • 6.7.5.3. Competitive scenario
    • 6.7.5.4. South Korea digital health for cardiovascular market estimates and forecasts 2018 to 2030 (USD Million)
  • 6.7.6. Singapore
    • 6.7.6.1. Key country dynamics
    • 6.7.6.2. Regulatory framework/ reimbursement structure
    • 6.7.6.3. Competitive scenario
    • 6.7.6.4. Singapore digital health for cardiovascular market estimates and forecasts 2018 to 2030 (USD Million)
• 6.8. Latin America
  • 6.8.1. Brazil
    • 6.8.1.1. Key country dynamics
    • 6.8.1.2. Regulatory framework/ reimbursement structure
    • 6.8.1.3. Competitive scenario
    • 6.8.1.4. Brazil digital health for cardiovascular market estimates and forecasts 2018 to 2030 (USD Million)
  • 6.8.2. Argentina
    • 6.8.2.1. Key country dynamics
    • 6.8.2.2. Regulatory framework/ reimbursement structure
    • 6.8.2.3. Competitive scenario
    • 6.8.2.4. Argentina digital health for cardiovascular market estimates and forecasts 2018 to 2030 (USD Million)
• 6.9. MEA
  • 6.9.1. South Africa
    • 6.9.1.1. Key country dynamics
    • 6.9.1.2. Regulatory framework/ reimbursement structure
    • 6.9.1.3. Competitive scenario
    • 6.9.1.4. South Africa digital health for cardiovascular market estimates and forecasts 2018 to 2030 (USD Million)
  • 6.9.2. Saudi Arabia
    • 6.9.2.1. Key country dynamics
    • 6.9.2.2. Regulatory framework/ reimbursement structure
    • 6.9.2.3. Competitive scenario
    • 6.9.2.4. Saudi Arabia digital health for cardiovascular market estimates and forecasts 2018 to 2030 (USD Million)
  • 6.9.3. UAE
    • 6.9.3.1. Key country dynamics
    • 6.9.3.2. Regulatory framework/ reimbursement structure
    • 6.9.3.3. Competitive scenario
    • 6.9.3.4. UAE digital health for cardiovascular market estimates and forecasts 2018 to 2030 (USD Million)
  • 6.9.4. Kuwait
    • 6.9.4.1. Key country dynamics
    • 6.9.4.2. Regulatory framework/ reimbursement structure
    • 6.9.4.3. Competitive scenario
    • 6.9.4.4. Kuwait digital health for cardiovascular market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 7. Competitive Landscape

• 7.1. Recent Developments & Impact Analysis, By Key Market Participants
• 7.2. Company/Competition Categorization
• 7.3. Company Position Analysis (Heatmap Analysis)
• 7.4. Company Profiles
  • 7.4.1. Epic Systems Corporation
    • 7.4.1.1. Company overview
    • 7.4.1.2. Financial performance
    • 7.4.1.3. Product benchmarking
    • 7.4.1.4. Strategic initiatives
  • 7.4.2. Orange Business
    • 7.4.2.1. Company overview
    • 7.4.2.2. Financial performance
    • 7.4.2.3. Product benchmarking
    • 7.4.2.4. Strategic initiatives
  • 7.4.3. Apple, Inc.
    • 7.4.3.1. Company overview
    • 7.4.3.2. Financial performance
    • 7.4.3.3. Product benchmarking
    • 7.4.3.4. Strategic initiatives
  • 7.4.4. Siemens Healthineers AG
    • 7.4.4.1. Company overview
    • 7.4.4.2. Financial performance
    • 7.4.4.3. Product benchmarking
    • 7.4.4.4. Strategic initiatives
  • 7.4.5. NXGN Management, LLC.
    • 7.4.5.1. Company overview
    • 7.4.5.2. Financial performance
    • 7.4.5.3. Product benchmarking
    • 7.4.5.4. Strategic initiatives
  • 7.4.6. GE HealthCare
    • 7.4.6.1. Company overview
    • 7.4.6.2. Financial performance
    • 7.4.6.3. Product benchmarking
    • 7.4.6.4. Strategic initiatives
  • 7.4.7. CardiAI
    • 7.4.7.1. Company overview
    • 7.4.7.2. Financial performance
    • 7.4.7.3. Product benchmarking
    • 7.4.7.4. Strategic initiatives
  • 7.4.8. Ultromics Limited.
    • 7.4.8.1. Company overview
    • 7.4.8.2. Financial performance
    • 7.4.8.3. Product benchmarking
    • 7.4.8.4. Strategic initiatives
  • 7.4.9. Cardiologs
    • 7.4.9.1. Company overview
    • 7.4.9.2. Financial performance
    • 7.4.9.3. Product benchmarking
    • 7.4.9.4. Strategic initiatives
  • 7.4.10. Ultrasight
    • 7.4.10.1. Company overview
    • 7.4.10.2. Financial performance
    • 7.4.10.3. Product benchmarking
    • 7.4.10.4. Strategic initiatives
  • 7.4.11. HeartVista Inc. (Vista.ai)
    • 7.4.11.1. Company overview
    • 7.4.11.2. Financial performance
    • 7.4.11.3. Product benchmarking
    • 7.4.11.4. Strategic initiatives
  • 7.4.12. Viz.ai, Inc.
    • 7.4.12.1. Company overview
    • 7.4.12.2. Financial performance
    • 7.4.12.3. Product benchmarking
    • 7.4.12.4. Strategic initiatives
  • 7.4.13. RSIP Vision
    • 7.4.13.1. Company overview
    • 7.4.13.2. Financial performance
    • 7.4.13.3. Product benchmarking
    • 7.4.13.4. Strategic initiatives
  • 7.4.14. Cleerly, Inc.
    • 7.4.14.1. Company overview
    • 7.4.14.2. Financial performance
    • 7.4.14.3. Product benchmarking
    • 7.4.14.4. Strategic initiatives